Publicacións en colaboración con investigadores/as de Universidad de Sevilla (19)

2024

  1. Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain

    Neuropathology and Applied Neurobiology, Vol. 50, Núm. 1

2023

  1. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories

    REC: CardioClinics, Vol. 58, Núm. 2, pp. 119-128

  2. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Revista Clinica Espanola

  3. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Cirugia Cardiovascular, Vol. 30, Núm. 3, pp. 174-181

  4. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Nefrologia, Vol. 43, Núm. 4, pp. 474-483

  5. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 7, pp. 501-510

  6. Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: What parameters should a basic lipid profile include?

    Revista clinica espanola, Vol. 223, Núm. 7, pp. 440-449

  7. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿qué parámetros debe incluir un perfil lipídico básico?

    Advances in Laboratory Medicine, Vol. 4, Núm. 2, pp. 147-156

  8. Expanded and Independent Spanish Validation of the MDS-Non Motor Rating Scale

    Movement Disorders Clinical Practice, Vol. 10, Núm. 4, pp. 586-595

  9. Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program

    Epilepsia Open, Vol. 8, Núm. 3, pp. 918-929

  10. Using network analysis to explore the validity and influential items of the Parkinson's Disease Questionnaire-39

    Scientific reports, Vol. 13, Núm. 1, pp. 7221

2022

  1. Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 122-131

  2. Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke

    Brain, Vol. 145, Núm. 7, pp. 2394-2406

2021

  1. Clinical characteristics and outcomes of thymoma-associated myasthenia gravis

    European Journal of Neurology, Vol. 28, Núm. 6, pp. 2083-2091

  2. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

    BMC Neurology, Vol. 21, Núm. 1

2019

  1. Complete assembly of the genome of an Acidovorax citrulli strain reveals a naturally occurring plasmid in this species

    Frontiers in Microbiology, Vol. 10, Núm. JUN

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

  2. Chronic and progressive Parkinson's disease MPTP model in adult and aged mice

    Journal of Neurochemistry, Vol. 136, Núm. 2, pp. 373-387

2013

  1. Neuroprotective and reparative effects of carotid body grafts in a chronic MPTP model of Parkinson's disease

    Neurobiology of Aging, Vol. 34, Núm. 3, pp. 902-915